HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Kato Selected Research

2,2'-methylenebis(1,3-cyclohexanedione)

12/2001Inhibitory effect of M50054, a novel inhibitor of apoptosis, on anti-Fas-antibody-induced hepatitis and chemotherapy-induced alopecia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Kato Research Topics

Disease

60Neoplasms (Cancer)
01/2021 - 02/2000
19Infections
12/2021 - 01/2000
14Carcinoma (Carcinomatosis)
07/2004 - 01/2000
11Carcinogenesis
11/2004 - 03/2000
8Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2017 - 05/2000
8Adenocarcinoma
09/2007 - 01/2000
7Stomach Neoplasms (Stomach Cancer)
01/2021 - 09/2001
7Brain Neoplasms (Brain Tumor)
01/2010 - 01/2007
7Hyperthermia
01/2010 - 01/2007
7Myocarditis (Carditis)
12/2003 - 01/2000
6Graft vs Host Disease (Graft-Versus-Host Disease)
01/2018 - 02/2000
6Aplastic Anemia (Anemia, Hypoplastic)
12/2017 - 10/2000
6Hemorrhage
01/2014 - 03/2001
6Neoplasm Metastasis (Metastasis)
03/2009 - 03/2001
5Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 06/2006
5Pain (Aches)
01/2021 - 12/2000
5Esophageal Neoplasms (Esophageal Cancer)
11/2020 - 01/2008
5Type 2 Diabetes Mellitus (MODY)
12/2018 - 05/2000
5Leukemia
01/2018 - 04/2013
5Hypertension (High Blood Pressure)
12/2017 - 04/2008
5Endometrial Neoplasms (Endometrial Cancer)
01/2014 - 10/2000
5Brain Injuries (Brain Injury)
01/2010 - 01/2006
5Rheumatoid Arthritis
07/2007 - 08/2001
5Heart Failure
10/2001 - 01/2000
4Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 01/2016
4Lymphoma (Lymphomas)
01/2018 - 04/2000
4Ovarian Neoplasms (Ovarian Cancer)
01/2016 - 02/2000
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2013 - 05/2000
4Body Weight (Weight, Body)
08/2008 - 01/2000
4Prostatic Neoplasms (Prostate Cancer)
11/2002 - 08/2000
4Glioma (Gliomas)
12/2001 - 01/2001
4Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
06/2001 - 01/2000
3Nausea
01/2019 - 01/2018
3Disease Progression
01/2019 - 12/2003
3Vascular Diseases (Vascular Disease)
06/2018 - 01/2000
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2018 - 11/2000
3Prediabetic State (Prediabetes)
12/2017 - 06/2017
3Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
03/2016 - 02/2000
3Hepatocellular Carcinoma (Hepatoma)
06/2014 - 01/2000
3Inflammation (Inflammations)
08/2010 - 08/2000
3Pancreatic Neoplasms (Pancreatic Cancer)
05/2008 - 03/2001
3Stomach Ulcer (Gastric Ulcer)
01/2007 - 01/2000
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2006 - 08/2000
3Ischemia
01/2003 - 02/2001
3Breast Neoplasms (Breast Cancer)
12/2002 - 08/2000
3Fibrosis (Cirrhosis)
11/2001 - 08/2000
2Fatigue
01/2022 - 08/2016
2Cicatrix (Scar)
01/2019 - 04/2000

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
06/2012 - 01/2000
7AntigensIBA
11/2020 - 02/2000
7Glucose (Dextrose)FDA LinkGeneric
12/2017 - 09/2000
7DNA (Deoxyribonucleic Acid)IBA
01/2015 - 07/2001
6Pharmaceutical PreparationsIBA
01/2021 - 03/2000
6Messenger RNA (mRNA)IBA
08/2008 - 01/2000
5Peptides (Polypeptides)IBA
11/2020 - 04/2000
5LigandsIBA
11/2020 - 11/2004
5Biomarkers (Surrogate Marker)IBA
06/2018 - 07/2007
5Phosphotransferases (Kinase)IBA
06/2016 - 01/2001
5AgarIBA
01/2010 - 01/2007
5CytokinesIBA
05/2009 - 03/2000
4Biological ProductsIBA
06/2011 - 09/2001
4Shape Memory AlloysIBA
01/2010 - 01/2007
4LipidsIBA
08/2008 - 08/2000
4ElementsIBA
01/2008 - 01/2006
3Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 06/2006
3HDL CholesterolIBA
06/2018 - 05/2015
3Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
12/2017 - 09/2001
3Anti-Bacterial Agents (Antibiotics)IBA
06/2014 - 11/2001
3AntibodiesIBA
05/2014 - 02/2001
3Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
05/2014 - 02/2000
3SteroidsIBA
05/2014 - 10/2000
3CollagenIBA
03/2011 - 03/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2009 - 03/2000
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
09/2007 - 01/2000
3Immunoglobulin G (IgG)IBA
04/2006 - 09/2001
3Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
04/2006 - 10/2000
3EnzymesIBA
04/2003 - 03/2000
3FluoridesIBA
01/2002 - 05/2000
3Crystallins (Crystallin)IBA
12/2001 - 02/2001
3Insulin (Novolin)FDA Link
08/2001 - 05/2000
3VimentinIBA
08/2001 - 02/2000
3CarcinogensIBA
05/2001 - 03/2000
2NivolumabIBA
01/2021 - 01/2019
2HLA Antigens (Human Leukocyte Antigens)IBA
11/2020 - 01/2018
2Cancer VaccinesIBA
11/2020 - 10/2001

Therapy/Procedure

28Therapeutics
01/2019 - 05/2000
25Drug Therapy (Chemotherapy)
01/2022 - 04/2000
15Transplantation
01/2018 - 05/2000
9Cell Transplantation
01/2016 - 04/2013
9Bone Marrow Transplantation (Transplantation, Bone Marrow)
09/2001 - 02/2000
7Hematopoietic Stem Cell Transplantation
01/2017 - 12/2005
5Radiotherapy
01/2021 - 01/2001
4Stem Cell Transplantation
06/2013 - 04/2001
4Stents
10/2009 - 05/2000
4Oral Administration
10/2001 - 08/2000
3Chemoradiotherapy
10/2017 - 01/2008
3Hysterectomy
09/2007 - 10/2000
3Aftercare (After-Treatment)
08/2007 - 03/2000
3Liver Transplantation
07/2001 - 11/2000
2Punctures
01/2021 - 10/2007